EUVIMEDEUVIMED entdecken
Open Access · CC0

Antibody response to Aedes aegypti D7L1 + 2 salivary proteins as marker of aggregate vector exposure and correlate of dengue virus susceptibility

Lauren E Bahr iD, Marco Hamins-Puertolas, Darunee Buddhari, Ivona Petzlova, Fabiano Oliveira, Stephen J Thomas, Saravanan Thangamani, Adam T Waickman iD, Kathryn B Anderson

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Lauren E Bahr und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, New York, United States of America. Hauptthemen laut MEDLINE: Aedes, Salivary Proteins and Peptides, Dengue Virus, Mosquito Vectors. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, State of New York, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aedes aegypti mosquitoes transmit several arboviruses of public health importance. Among these is dengue virus (DENV), a flavivirus whose global infection rates continue to rise each year. With limited options available for preventing or treating DENV infections, mosquito control remains the most widely implemented strategy to combat DENV transmission. Due to the global distribution of DENV, which infects an estimated 400 million people per year, vector suppression practices vary drastically by country and/or region and even small differences in microenvironment can significantly impact vector abundance. There remains a significant need to better understand vector exposure rates at an individual level to disentangle vector exposure and arboviral infection rates. To this end, we have optimized a serologic assay to assess the abundance of antibodies directed against the mosquito salivary proteins AeD7L1 + 2 as a surrogate metric of vector exposure. Utilizing this assay, we found that anti-AeD7L1 + 2 IgG levels were unable to identify low levels of Aedes exposure in individuals with limited prior Aedes exposure, indicating they are unreliable markers of an individual’s recent exposure to low levels of these vectors. However, antibody levels against AeD7L1 + 2 were robust in plasma samples from individuals living in Aedes endemic regions. These antibody levels reflected seasonal changes in Aedes abundance and exposure, indicating their potential for use as an aggregate marker of vector exposure. Additionally, we found that there were negative associations with anti-AeD7L1 + 2 IgG levels and age in our cohort. Interestingly, we also found that lower titers of anti-AeD7L1 + 2 IgG correlated with higher infection burden in households. This finding has implications for the potential interaction between AeD7L1 + 2 proteins or anti-AeD7L1 + 2 antibodies and DENV during infection events that will require further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AedesSalivary Proteins and PeptidesDengue VirusMosquito VectorsInsect ProteinsDengueAnimalsHumansFemaleMaleAdultImmunoglobulin GBiomarkersMiddle AgedAntibody FormationYoung AdultAdolescentAntibodies, Viral

Substanzen

Salivary Proteins and PeptidesInsect ProteinsImmunoglobulin GBiomarkersAntibodies, Viral

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, New York, United States of America.
  • Department of Medicine, University of California, San Francisco, California, United States of America.
  • Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
  • Institute for Global Health and Translational Sciences, State University of New York Upstate Medical University, Syracuse, New York, United States of America.
  • SUNY Center for Vector-Borne Diseases, State University of New York Upstate Medical University, Syracuse, New York, United States of America.
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

ORCID-Profile: Lauren E Bahr, Adam T Waickman

Förderung

  • NIAID NIH HHS
  • State of New York
  • National Institute of Health

Zitieren

APA

Bahr, L. E., Hamins-Puertolas, M., Buddhari, D., Petzlova, I., Oliveira, F., Thomas, S. J., Thangamani, S., Waickman, A. T., & Anderson, K. B. (2025). Antibody response to Aedes aegypti D7L1 + 2 salivary proteins as marker of aggregate vector exposure and correlate of dengue virus susceptibility. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013099

Vancouver

Bahr LE, Hamins-Puertolas M, Buddhari D, Petzlova I, Oliveira F, Thomas SJ, et al. Antibody response to Aedes aegypti D7L1 + 2 salivary proteins as marker of aggregate vector exposure and correlate of dengue virus susceptibility. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013099

BibTeX
@article{Bahr2025,
  author = {Bahr, Lauren E and Hamins-Puertolas, Marco and Buddhari, Darunee and Petzlova, Ivona and Oliveira, Fabiano and Thomas, Stephen J and Thangamani, Saravanan and Waickman, Adam T and Anderson, Kathryn B},
  title = {Antibody response to Aedes aegypti D7L1 + 2 salivary proteins as marker of aggregate vector exposure and correlate of dengue virus susceptibility},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013099}
}
Kostenlos starten →